跳至主要内容
临床试验/CTRI/2025/03/083421
CTRI/2025/03/083421尚未招募2/3 期

Open Randomised Control Clinical Trial of Haridradi Anjana in Shushkakshipaka with Special Reference to Dry Eye Syndrome.

Dr Swapnil Madan Bilari1 个研究点 分布在 1 个国家目标入组 76 人开始时间: 2025年4月7日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
76
试验地点
1
主要终点
Haridradi Anjana is effective in Shushkashipaka

研究概览

简要总结

The condition is more common among the people irrespective of their age. Dry Eye Syndrome can have remarkable impact on visual function, daily activities, social and physical functioning, workplace productivity and quality of life. Recently due to Covid Crises use of visual electronic devices has been increased tremendously. This is adversely affecting the eye health. Extended period of visual device use may lead to eye-strain, dryness of eyes, vision related problems and many more.

While working in Shalakyatantra (Netrarog) OPD researcher sees a good number of patients with the complaints of the same. This (4)provoked to study on this disease, as Prevalance ranges from 5% to 35% worldwide. While in India it is 29.25% based on ocular surface disease index data

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients suffering from symptoms of shuskakshipak(Netrashushkata, Daha ,Gharsha, Aavildarshanam, Krichronmeelanimeelana, etc.)
  • Patients of age group between 18-70yrs irrespective of gender,socioeconomical status, religious status.
  • Patients having excessive outdoor and indoor work exposed to sunlight for more than 3hrs.
  • Patients having software profession, those who gets exposed to visual devices daily for longer duration more than 3 hrs.
  • Patients willing to take part in treatment.

排除标准

  • 未提供

结局指标

主要结局

Haridradi Anjana is effective in Shushkashipaka

时间窗: Once a day for 7 days

次要结局

  • Hydroxymethylcellulose 2 % eye gel is effective in Shushkashipaka(Once in night for 7 days)

研究者

发起方
Dr Swapnil Madan Bilari
申办方类型
Other []
责任方
Principal Investigator
主要研究者

Dr Swapnil Madan Bilari

Hon Shri Annasaheb Dange Ayurved Medical College and Post Graduate research centre Ashta

研究点 (1)

Loading locations...

相似试验